__________________________________________________________________________________________
Re: Local ID TH140602812 / TH201406007512 FU (1)
Thank you for reporting to us an adverse event related to Lilly product.
We would like to collect more information to better understanding the reported event.
Please respond to following questions regarding the adverse event – difficulty breathing, involving a male patient, 77 Yrs who was subscribed Forteo, reported the event to Lilly on 19/JUN/2014.
Please follow up for the following information with the initial reporter:
1. Relevant medical history
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
2. Concomitant medications
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
3. Did the patient receive any corrective treatment for the breathing difficulties?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
4. Did the patient recover fully from the event?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
5. After stopping teriparatide, did the patient continue with the treatment?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
6. Did the event appear after resuming therapy?
____________________________________________________________________________
____________________________________________________________________________
____________________________________________________________________________
Thanks
Yours sincerely,
ELI LILLY AND COMPANY
Sasithorn Suntharo
Pharmacovigilance Associate
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: